PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
Purified anti-β-Amyloid, 1-42 , 1 ml
Purified anti-β-Amyloid, 1-42 , 200 μl
Purified anti-β-Amyloid, 1-42 , 500 μl
Purified anti-β-Amyloid, 1-43 , 200 μl
Purified anti-β-Amyloid, 17-24 , 1 ml
Purified anti-β-Amyloid, 17-24 , 200 μl
Purified anti-β-Amyloid, 17-24 , 500 μl
Purified anti-β-Amyloid, 1-8, 1 ml
Purified anti-β-Amyloid, 1-8, 200 μl
Purified anti-β-Amyloid, x-38, 50 μg
Purified anti-β-Amyloid, x-42, 50 μg
Purified anti-β-Dystroglycan, 100 µg
Purified anti-β-Dystroglycan, 25 µg
Purified anti-β-Tubulin, 250 μl
Purified Non-muscle Myosin Heavy Chain II-A, 100 μl
Purified Non-muscle Myosin Heavy Chain II-B, 100 μl